Quantamental Technologies LLC Uni Qure N.V. Transaction History

Quantamental Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $118,572 - $236,718	10,663 New	10,663 $122,000
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $14,852 - $29,848	-400 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$39.36 - $76.8 $15,744 - $30,720	400 New	400 $16,000
Q2 2019 Aug 12, 2019	SELL	$52.76 - $82.19 $15,828 - $24,657	-300 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$27.39 - $68.41 $8,217 - $20,523	-300 Reduced 50.0%	300 $18,000
Q4 2018 Jan 28, 2019	BUY	$22.8 - $33.93 $13,680 - $20,358	600 New	600 $17,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.